S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study

  • Harris S
  • Feagan B
  • Hanauer S
  • et al.
N/ACitations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Harris, S., Feagan, B. G., Hanauer, S. B., Vermeire, S., Ghosh, S., Yan, J., … D’Haens, G. R. (2023). S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study. American Journal of Gastroenterology, 118(10S), S867–S868. https://doi.org/10.14309/01.ajg.0000954176.61528.15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free